CXCL10 and systemic lupus erythematosus: There were two studies that compared the presence of serum IP-10 in patients with SLE and non-SLE patients with other connective tissue diseases (19 rheumatoid arthritis, 21 systemic sclerosis, and 28 polymyositis/dermatomyositis).